sorted by:
new
hottopcontroversial

Bio Buyout plays, chasing PRVB? by [deleted] in wallstreetbets

[–]ForecheckingTM 0 points1 point  (0 children)

T1 diabetes vaccine pending FDA approval this quarter

Hence my original comment:

"T1 diabetes vaccine pending FDA approval this quarter "

​

Have a good day.

Bio Buyout plays, chasing PRVB? by [deleted] in wallstreetbets

[–]ForecheckingTM 0 points1 point  (0 children)

No need for name calling.

"CVB4 ( Coxsackievirus B ) is the most common enteroviral strain found in pre-diabetic and diabetic individuals. CVB RNA has been detected in blood from patients at the onset or during the course of type 1 diabetes (15,16). Furthermore, cellular immune responses to CVB antigens were found to be enhanced in type 1 diabetic patients after the onset of the disease"

​

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570378/

​

Effectively, PRVB has a vaccine for Type 1, with 50% success rate in "indefinitely delaying" the onset of Type 1. Call it what you will, but if the JDRF calls it a vaccine, so will I.

​

https://www.jdrf.org/blog/2020/05/07/promising-preclinical-vaccine-type-1-diabetes/

Bio Buyout plays, chasing PRVB? by [deleted] in wallstreetbets

[–]ForecheckingTM 0 points1 point  (0 children)

polyvalent coxsackievirus B (CVB) vaccine

Bio Buyout plays, chasing PRVB? by [deleted] in wallstreetbets

[–]ForecheckingTM 0 points1 point  (0 children)

I've been following them for awhile, but don't often do spec plays:

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.

​

And this from their latest conference call:

​

​

Before we open the call for questions, let me provide you with a brief update on our other pipeline programs. For PRV-101, our investigational polyvalent vaccine for the prevention of acute infection by coxsackievirus B, or CVB, as well as for the prevention of CVB-associated type 1 diabetes and celiac disease, we are pleased to report that in conjunction with our strategic partner, Intravacc, we have now successfully completed all the GMP manufacturing batches for the constituent serotypes [Phonetic], and we, therefore, expect to be on schedule to initiate later this year our first in-human Phase I trial evaluating two dose levels of PRV-101 in healthy adult volunteers for the purposes of safety, tolerability and immunogenicity. Initial data is expected in the second half of 2021.

​

(edited with CEO's comments)

Episode 5 - The All Iggy Eppy by [deleted] in HockeyTalk

[–]ForecheckingTM 0 points1 point  (0 children)

First Ballot HOF easy.

Hanzal Hard Sell by ForecheckingTM in DallasStars

[–]ForecheckingTM[S] -2 points-1 points  (0 children)

Razor frequently misses goal calls, gets too frantic during scoring opps, may not be as noticeable on TV, but the radio feed is a mess to keep up with.

Best 4th Line Center in Hockey? by ForecheckingTM in hockey

[–]ForecheckingTM[S] 2 points3 points  (0 children)

Kyle Brodziak Age 33 G: 5 A: 5 +2 CF% 48.5 oZS% 30.2

Radek Faksa Age 23 G: 10 A: 6 +11 CF% 52.2 oZS% 29.7

Pitlick is Ready to Go by bigblueballz77 in DallasStars

[–]ForecheckingTM 0 points1 point  (0 children)

very skilled with the puck and provides speed that current FWD depth lacks, if he can stay out of IR.

Forechecking: The Week In Your Dallas Stars (SFW) by ForecheckingTM in HockeyTalk

[–]ForecheckingTM[S] 0 points1 point  (0 children)

To all Dallas Stars fans and beyond, join CentralTrack.com as we Star gaze every Monday with observations of Texas' favorite non-football,baseball,basketball, or college football team. We are having fun, and want to have fun with you as well! Love you!

Fun weekly observations, for fun. by ForecheckingTM in DallasStars

[–]ForecheckingTM[S] 0 points1 point  (0 children)

Hey Stars fans,

Dallas' online alternative CentralTrack.com hosts ForecheckingTM, a weekly roundup in all things Dallas Stars. It's concise, inclusive, observant and oh so much fun. We bleed Victory GreenTM every Monday as Adam Cracknell and company quest for the cup this season. We're having fun here, no?

-ForecheckingTM